Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
(626)
•••
ark88
X
View Profile
View Bullboard History
Comment by
ark88
on Jun 17, 2022 10:31am
RE:News next week
https://twitter.com/SironaBiochem/status/1537767167235596288
(23)
•••
Assyla
X
View Profile
View Bullboard History
Post by
Assyla
on Jun 17, 2022 10:10am
News next week
Can't wait to find out what other good things coming next week. It will most likely be a new big partnership.
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Jun 17, 2022 9:30am
Welcome to the new shareholders
With this huge deal with AbbVie and Elanco deal close Sirona is finally getting recognized bigtime! The share price will reflect in due time. At this level to buy is a gift. Welcome to all new
...more
(32)
•••
noclue80
X
View Profile
View Bullboard History
Comment by
noclue80
on Jun 17, 2022 8:23am
RE:RE:new tweet from SBM
agree.. wouldn't be surprised if they would announce to engage Linda in TFC-039 negotiations..
(32)
•••
noclue80
X
View Profile
View Bullboard History
Post by
noclue80
on Jun 17, 2022 8:04am
new tweet from SBM
We are back from the BIO International Convention in San Diego. The interest in our pipeline and the company in general has never been so high! We have had very in-depth discussions with potential
...more
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jun 17, 2022 7:37am
RE:RE:RE:RE:RE:So
I am not so sure that AbbVie took advantage of their size and resources in an unfair manner when closing the 1067 transaction. Skin and face are very much the core of Allergan´s
...more
(30)
•••
jimmyhorizon
X
View Profile
View Bullboard History
Comment by
jimmyhorizon
on Jun 17, 2022 7:30am
RE:RE:RE:Nice bid this morning
What does that mean?
(32)
•••
noclue80
X
View Profile
View Bullboard History
Post by
noclue80
on Jun 17, 2022 6:38am
PRC Partners - in-depth analysis postponed to next week.
PRC Partners on Twitter: "@SironaBiochem in-depth analysis postponed to next week. We anticipate more updates and we want to include it in our evaluation. Stay tuned! #stockanalysis #stockmarket
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jun 17, 2022 3:57am
RE:RE:RE:RE:So
The anti-wrinkle is head to head to Botox. I'd prefer a competitor to AbbVie/Allergan as the partner to avoid the risk of killing the competiion by licensing the compound, pay upfront and then
...more
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 17, 2022 1:09am
RE:RE:RE:So
Keep Linda on to negotiate the R&D partnership or else mgmt bozos will blow it... TFC-1326 anti-aging / anti-wrinkle "In discussion for R&D partnership."
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 16, 2022 9:18pm
RE:So
Did Linda give a departure speech - I must have missed it.
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Jun 16, 2022 4:02pm
Health Canada seizes unauthorized skin lightening products
https://www.newswire.ca/news-releases/advisory-health-canada-seizes-unauthorized-skin-lightening-and-sex-enhancement-products-in-lethbridge-and-calgary-ab-because-they-may-pose-serious-health-risks
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 16, 2022 1:20pm
RE:RE:RE:RE:RE:Nice bid this morning
if he is even the ceo.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Jun 16, 2022 1:04pm
RE:RE:RE:RE:Nice bid this morning
You are absolutely correct. On top of that, insti's and fund managers will demand quarterly conference calls followed by a question period. They will ask very direct probing questions based
...more
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >